We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

New and Nonofficial Remedies, 1941 Containing Descriptions of the Articles Which Stand Accepted by the Council on Pharmacy and Chemistry of the American Medical Association on January 1, 1941

JAMA. 1941;117(16):1399. doi:10.1001/jama.1941.02820420091039.
Text Size: A A A
Published online


The increasing size of New and Nonofficial Remedies in the last few years is concrete evidence of the recent advances in chemotherapy and of the increasing value being placed by pharmaceutical manufacturers and distributors on acceptance of their products by the Council on Pharmacy and Chemistry. Nothwithstanding the numerous deletions recorded in the preface, this year's volume is substantially larger than the 1940 edition.

This year's new additions include the new sulfanilamide derivatives sulfathiazole as well as sulfapyridine sodium; antipneumococcic rabbit serum of types I, II, III, V, VII and VIII; human convalescent measles serum and human convalescent scarlet fever serum, and staphylococcus antitoxin. The field of endocrinology is represented by the addition of chorionic gonadotropin (follutein). The addition of shark liver oil reflects the search for new sources of vitamins A and D caused by the cutting off of foreign cod liver oil. Other newly accepted preparations are ampules


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.